Allegheny Financial Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Allegheny Financial Group’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,500	Closed	-$225K	–	172
2022 Q4	$225K	Hold	10,500	–	–	0.09%	150
2022 Q3	$188K	Hold	10,500	–	–	0.09%	150
2022 Q2	$101K	Hold	10,500	–	–	0.05%	158
2022 Q1	$177K	Hold	10,500	–	–	0.07%	152
2021 Q4	$176K	Hold	10,500	–	–	0.07%	150
2021 Q3	$171K	Hold	10,500	–	–	0.08%	142
2021 Q2	$66K	Hold	10,500	–	–	0.03%	151
2021 Q1	$65K	Buy	10,500 +500	+5%	+$3.04K	0.05%	100
2020 Q4	$69K	Buy	+10,000	New	+$64K	0.04%	127

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Allegheny Financial Group's ISEE Position: Q1 2023 in Review

Allegheny Financial Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2023, closing a stake of 10,500 shares — an estimated $225K sold.

Allegheny Financial Group first reported a position in ISEE in Q4 2020 and held it in 9 quarters. The position peaked at $225K in Q4 2022. 223 funds tracked by Wall St. Rank hold ISEE as of Q1 2023.

Allegheny Financial Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Allegheny Financial Group sold 10,500 IVERIC bio, Inc. Common Stock shares in Q1 2023, an estimated $225K.
Allegheny Financial Group first reported a position in IVERIC bio, Inc. Common Stock in Q4 2020 and held it in 9 quarters.
Allegheny Financial Group's IVERIC bio, Inc. Common Stock position peaked at $225K in Q4 2022.
223 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2023.

Based on Allegheny Financial Group's 13F filing for Q1 2023, filed 5 May 2023.